Raymond James & Associates boosted its stake in UiPath Inc. (NYSE:PATH – Free Report) by 40.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 230,331 shares of the healthcare company’s stock after purchasing an additional 66,114 shares during the period. Raymond James & Associates’ holdings in UiPath were worth $2,921,000 at the end of the most recent quarter.
A number of other hedge funds have also added to or reduced their stakes in PATH. Mark Sheptoff Financial Planning LLC purchased a new position in shares of UiPath during the 4th quarter worth $25,000. ORG Partners LLC lifted its position in UiPath by 875.6% during the first quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company’s stock valued at $27,000 after purchasing an additional 1,112 shares in the last quarter. GAMMA Investing LLC bought a new stake in UiPath during the fourth quarter valued at about $36,000. Lindbrook Capital LLC increased its position in UiPath by 46.0% in the first quarter. Lindbrook Capital LLC now owns 2,027 shares of the healthcare company’s stock worth $46,000 after buying an additional 639 shares in the last quarter. Finally, Benjamin F. Edwards & Company Inc. raised its stake in shares of UiPath by 122.5% in the first quarter. Benjamin F. Edwards & Company Inc. now owns 2,556 shares of the healthcare company’s stock worth $58,000 after buying an additional 1,407 shares during the period. 62.50% of the stock is currently owned by hedge funds and other institutional investors.
UiPath Price Performance
UiPath stock opened at $12.88 on Monday. UiPath Inc. has a 1-year low of $10.37 and a 1-year high of $27.87. The firm has a market capitalization of $7.38 billion, a P/E ratio of -80.50 and a beta of 0.86. The company’s 50-day moving average is $12.18 and its 200 day moving average is $17.04.
Wall Street Analysts Forecast Growth
Read Our Latest Research Report on UiPath
UiPath Profile
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Recommended Stories
- Five stocks we like better than UiPath
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Don’t Overlook Campbell Soup: Here’s What Could Drive Its Stock
- How to Calculate Inflation Rate
- Birkenstock’s Sudden Slide—Why It Might Be Your Next Big Win
- How to Read Stock Charts for Beginners
- Why Dell Can Continue Winning in AI and Beyond
Want to see what other hedge funds are holding PATH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UiPath Inc. (NYSE:PATH – Free Report).
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.